Anthropic Buys Biotech Startup Coefficient Bio for $400M

Anthropic, the AI safety company behind Claude, has made a major strategic acquisition, purchasing the stealth biotech AI startup Coefficient Bio for approximately $400 million in a stock deal. This acquisition signals Anthropic's decisive entry into the biotechnology sector, a field ripe for disruption by advanced AI. The move suggests Anthropic aims to integrate its expertise in large language models (LLMs) and constitutional AI with biological research and development. Potential applications could include using AI to accelerate drug discovery, model complex biological systems, design novel proteins, or interpret genomic data. This aligns with a broader trend where leading AI companies are applying frontier models to hard scientific problems, pushing AI from digital tools into the realm of physical discovery. The acquisition of Coefficient Bio provides Anthropic with specialized talent and technology to pioneer new applications at the intersection of AI and biology, potentially opening a significant new frontier for the company beyond its core chatbot and enterprise offerings.